EAH Stock Overview
ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide.
ECO Animal Health Group plc Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||UK£1.19|
|52 Week High||UK£3.26|
|52 Week Low||UK£0.81|
|1 Month Change||32.96%|
|3 Month Change||5.31%|
|1 Year Change||-62.22%|
|3 Year Change||-66.29%|
|5 Year Change||-81.02%|
|Change since IPO||257.00%|
Recent News & Updates
|EAH||GB Pharmaceuticals||GB Market|
Return vs Industry: EAH underperformed the UK Pharmaceuticals industry which returned -5.1% over the past year.
Return vs Market: EAH underperformed the UK Market which returned -16.2% over the past year.
|EAH Average Weekly Movement||8.2%|
|Pharmaceuticals Industry Average Movement||6.7%|
|Market Average Movement||5.4%|
|10% most volatile stocks in GB Market||10.7%|
|10% least volatile stocks in GB Market||2.8%|
Stable Share Price: EAH is more volatile than 75% of UK stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: EAH's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.
ECO Animal Health Group plc Fundamentals Summary
|EAH fundamental statistics|
Is EAH overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|EAH income statement (TTM)|
|Cost of Revenue||UK£47.06m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.01|
|Net Profit Margin||-0.83%|
How did EAH perform over the long term?See historical performance and comparison